Director of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), Foley Todd, sells 300 shares worth $7,512

According to Rhythm Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 30 04:35 PM, company Director, Foley Todd disclosed selling 300 shares at a cost of $25.04. At the time of this transaction (Jun 26), this trade was worth $7,512 in total. As of Jun 26, Foley Todd now owns 1,909,258 shares in total worth about $42,576,453.4.

For the last few recent trades made by Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Director, Foley Todd, we have the following information:

  1. SEC Form 4 filing: Jun 24: Sold 97,388 shares at the rate of $25.34 per share. Total worth of this trade was $2,467,812. Total number of shares owned as of Jun 24 were 1,927,505
  2. SEC Form 4 filing: Jun 25: Sold 17,947 shares at the rate of $25.41 per share. Total worth of this trade was $456,033. Total number of shares owned as of Jun 25 were 1,909,558
  3. SEC Form 4 filing: Jun 05: Sold 1,896 shares at the rate of $20.00 per share. Total worth of this trade was $37,920. Total number of shares owned as of Jun 05 were 2,024,893
Posted by on Tuesday June 30 2020, 5:36 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments closed, Trackbacks open. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in